HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Food Importing Unlikely For USPlabs Owner's Future

Executive Summary

FDA debars Matthew Hebert, USPlabs co-owner “with primarily responsibilities over product packaging design,” for five years from importing dietary ingredients or other articles of food.

You may also be interested in...

Elected Official In Louisiana Town Pleads Guilty In FDA Investigation Of ED-Spiked Supplements

Town’s website still identifies man as constable, an elected position serving “as the law enforcement arm of the Justice of the Peace Court," the local court.

After Leaving Prison, Former USPlabs Executive Will Have To Wait 4 Years To Import Supplements

FDA debars Jonathan Doyle for five years from importing food in US due to 2020 conviction through a guilty plea on a felony federal charge. Doyle scheduled for release from prison in September 2022; sentences for some co-defendants end sooner, some later.

Appetite In Congress For Adding Supplements To Pre-tax Savings Grows By Another House Bill

Reps. Brendan Boyle and Darin LaHood introduce Dietary Supplement Tax Fairness Ac to amend Internal Revenue Code to include some supplement products as qualified medical expenses.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts